TPEX:6712 Market Cap

TPEX:6712 has a market cap or net worth of 12.44 billion as of March 9, 2026. Its market cap has decreased by -14.56% in one year.

Market Cap

12.44B

Enterprise Value

12.13B

Revenue

1.01B

Ranking

n/a

PE Ratio

24.10

Stock Price

142.00

Market Cap Chart

Since October 26, 2018, TPEX:6712's market cap has increased from 5.10B to 12.44B, an increase of 144.09%. That is a compound annual growth rate of 12.88%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	12.66B	-11.89%
Dec 31, 2025	14.37B	1.47%
Dec 31, 2024	14.16B	-1.25%
Dec 29, 2023	14.34B	-4.57%
Dec 30, 2022	15.02B	15.46%
Dec 30, 2021	13.01B	32.03%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Medigen Vaccine Biologics	12.10B
Tanvex BioPharma	11.86B
TCM Biotech International	14.02B
AP Biosciences	14.46B
TaiMed Biologics	14.62B
Gongwin Biopharm Holdings	9.81B
EirGenix	18.10B
PharmaEngine	8.78B

Market Cap Rankings